Three months interval therapy of Eculizumab in a patient with atypical hemolytic uremic syndrome with hybrid CFHR1/CFH gene

Pregnancy-associated atypical hemolytic uremic syndrome (P-aHUS) is a rare condition. It is characterized by very high maternal mortality and morbidity. Most cases of P-aHUS (79%) manifest in the postpartum period; this is probably due to the complement’s involvement in aHUS pathogenesis. Eculizumab...

Full description

Saved in:
Bibliographic Details
Published in:CEN Case Rep
Main Authors: Alobaidi, Sami, AlDabbagh, Ammar, Alamoudi, Amany, Almowarey, Murad, AKL, Ahmed
Format: Artigo
Language:Inglês
Published: Springer Singapore 2019
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6450989/
https://ncbi.nlm.nih.gov/pubmed/30715674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-019-00383-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items